InsidersTradesSigma
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
9
Disclosed sells
1
T+90 hit rate
25%
T+90 mean return
-6.7%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by HEDRICK MARC H, Chairman & CEO. Officer active across 2 companies, notably Plus Therapeutics, INC.. In total, 11 reports have been logged. Split: 9 buys · 1 sell. Total volume traded: €59k. History available since 30 April 2021. The latest transaction was filed on 10 September 2024 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
8,000 shares@ US$1.229915.1% of flowCommon StockSEC:0000950170-24-105331:0
Ideal exit: 7 Jun 2025 (T+270)
12,255 shares@ US$2.0439.3% of flowCommon StockSEC:0000950170-24-057455:0
Ideal exit: 2 Feb 2025 (T+270)
2,068 shares@ US$1.95976.3% of flowCommon StockSEC:0001209191-23-058816:0
5,000 shares@ US$0.6480.0086% mcap13.3% of flowCommon StockSEC:0001209191-22-037240:0
Ideal exit: 12 Mar 2023 (T+270)
2,500 shares@ US$0.68410.0045% mcap6.9% of flowCommon StockSEC:0001209191-22-025901:0
Ideal exit: 21 Jan 2023 (T+270)
5,000 shares@ US$0.690.0090% mcap13.9% of flowCommon StockSEC:0001209191-22-025718:0
Ideal exit: 21 Jan 2023 (T+270)
2,500 shares@ US$1.65990.0099% mcap15.4% of flowCommon StockSEC:0001209191-21-061724:0
Ideal exit: 23 Jul 2022 (T+270)
2,500 shares@ US$1.659946.6% of flowCommon StockSEC:0001209191-21-061724
Ideal exit: 23 Jul 2022 (T+270)
2,183 shares@ US$2.276717.6% of flowCommon StockSEC:0001209191-21-029409
Ideal exit: 25 Jan 2022 (T+270)
2,183 shares@ US$2.27670.011% mcap17.6% of flowCommon StockSEC:0001209191-21-029409:0
Ideal exit: 25 Jan 2022 (T+270)
70,500 sharesCommon StockSEC:0001140361-16-049630:0
11 of 11 declarations
About HEDRICK MARC H
Marc H. Hedrick is the Chief Executive Officer of Plus Therapeutics, Inc. He leads the company by overseeing all operations and developing strategies for growth. His role is crucial for ensuring the success of the organization and meeting stakeholder needs.
